Clinical Trials List
Protocol NumberGBL15-001
2015-05-01 - 2017-06-30
Phase II
Terminated1
-
Trial Applicant
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 林孝義 Division of Rheumatology
- Wei-Sheng Chen Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Completed
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
約30 participants
-
Global
約30 participants
